These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 29498927)

  • 1. Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women.
    Sun Q; Zong G; Valvi D; Nielsen F; Coull B; Grandjean P
    Environ Health Perspect; 2018 Mar; 126(3):037001. PubMed ID: 29498927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
    Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-course Exposure to Perfluoroalkyl Substances in Relation to Markers of Glucose Homeostasis in Early Adulthood.
    Valvi D; Højlund K; Coull BA; Nielsen F; Weihe P; Grandjean P
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2495-2504. PubMed ID: 33890111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study.
    Liu G; Zhang B; Hu Y; Rood J; Liang L; Qi L; Bray GA; DeJonge L; Coull B; Grandjean P; Furtado JD; Sun Q
    Environ Health; 2020 Jan; 19(1):5. PubMed ID: 31931806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metabolites associated with exposure to perfluoroalkyl substances and risk of type 2 diabetes - A nested case-control study.
    Schillemans T; Shi L; Donat-Vargas C; Hanhineva K; Tornevi A; Johansson I; Koponen J; Kiviranta H; Rolandsson O; Bergdahl IA; Landberg R; Åkesson A; Brunius C
    Environ Int; 2021 Jan; 146():106180. PubMed ID: 33113464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluoroalkyl substances and risk of type II diabetes: A prospective nested case-control study.
    Donat-Vargas C; Bergdahl IA; Tornevi A; Wennberg M; Sommar J; Kiviranta H; Koponen J; Rolandsson O; Åkesson A
    Environ Int; 2019 Feb; 123():390-398. PubMed ID: 30622063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women.
    Zhou W; Zhang L; Tong C; Fang F; Zhao S; Tian Y; Tao Y; Zhang J;
    Environ Health Perspect; 2017 Jun; 125(6):067012. PubMed ID: 28657892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
    Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
    Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study.
    Hurley S; Goldberg D; Wang M; Park JS; Petreas M; Bernstein L; Anton-Culver H; Nelson DO; Reynolds P
    Environ Health; 2018 Nov; 17(1):83. PubMed ID: 30482205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
    Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
    Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study.
    Hu Y; Liu G; Rood J; Liang L; Bray GA; de Jonge L; Coull B; Furtado JD; Qi L; Grandjean P; Sun Q
    Environ Res; 2019 Dec; 179(Pt A):108775. PubMed ID: 31593837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.
    Cardenas A; Gold DR; Hauser R; Kleinman KP; Hivert MF; Calafat AM; Ye X; Webster TF; Horton ES; Oken E
    Environ Health Perspect; 2017 Oct; 125(10):107001. PubMed ID: 28974480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to novel and legacy per- and polyfluoroalkyl substances (PFASs) and associations with type 2 diabetes: A case-control study in East China.
    Han X; Meng L; Zhang G; Li Y; Shi Y; Zhang Q; Jiang G
    Environ Int; 2021 Nov; 156():106637. PubMed ID: 33993001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of exposure to perfluoroalkyl substances with serum uric acid change and hyperuricemia among Chinese women: Results from a longitudinal study.
    Feng Y; Fu M; Guan X; Wang C; Meng H; Zhou Y; He M; Guo H
    Chemosphere; 2022 Dec; 308(Pt 3):136438. PubMed ID: 36116625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States).
    Cluett R; Seshasayee SM; Rokoff LB; Rifas-Shiman SL; Ye X; Calafat AM; Gold DR; Coull B; Gordon CM; Rosen CJ; Oken E; Sagiv SK; Fleisch AF
    Environ Health Perspect; 2019 Aug; 127(8):87006. PubMed ID: 31433236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal exposure to perfluoroalkyl chemicals and anogenital distance in the offspring: A Faroese cohort study.
    Christensen JVR; Bangash KK; Weihe P; Grandjean P; Nielsen F; Jensen TK; Petersen MS
    Reprod Toxicol; 2021 Sep; 104():52-57. PubMed ID: 34182087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.